Strategic positioning Kingdom offers a new class of clinically-validated postbiotics tailored for pets, with two market-ready ingredients and several ongoing clinical studies, presenting a compelling opportunity to position alongside premium pet nutrition and supplement brands seeking differentiated efficacy claims.

Brand partnerships Act on Kingdom’s existing trust as an ingredient partner to top pet brands and their ongoing launches; target mid-to-large pet product players looking to enhance product performance with scientifically backed, pet-specific ingredients.

Clinical credibility Leverage 11 clinical studies and ground-up pet-specific design to craft sales pitches centered on validated efficacy and measurable outcomes, appealing to brands aiming to claim superior postbiotic performance in pet health solutions.

Growth signals With revenue in the mid-single-digit millions and a healthy funding cushion, Kingdom appears poised for scale; approach investors and strategic partners looking for growth-stage biotech suppliers with proven market traction and expansion potential.

Global expansion Given the international market activity in pet health and the development of a human Superculture ingredient, explore cross-market opportunities in human health applications and global pet brands seeking diversified, science-backed ingredients for broader product lines.